Summary Report of Consolidated Financial Results

February 9, 2007

For the Nine-Month Period ended December 31, 2006 (Fiscal Year ending March 31, 2007)
Code No.:8086
TSE/OSE-1st Section
Company name: NIPRO CORPORATION(URL: http://www.nipro.co.jp/)
Representative: Minoru Sano, President and Representative Director
Contact:
Akihiko Yamabe, Director, General Manager of Accounting & Corporate Planning Division
TEL (06) 6372-2331
1. Matters related to the preparation of quarterly financial summary(1) Adoption of simplified accounting treatments: N/A(2) Difference in the method of accounting treatment from the most recent fiscal year:
Accounting standard for net assets in balance sheet has been adopted since this accounting period.
(3) Changes in the scope of consolidation and application of the equity method: Adoption(Content: Added 3 entities, Removed 2 entities)
2. Business results and financial position for the nine months ended December 31, 2006 of the Fiscal Year ending
March 31, 2007(From April 1, 2006 to December 31, 2006).
(1) Result of Operations
Net Sales
OperatingRecurring
Net (Quarter)
IncomeIncomeIncomeMillions of Yen% Millions of Yen% Millions of Yen% Millions of Yen%
145,796 (6.6)
10,012 (5.3)
9,139 (16.6)
8,530 85.0
Nine months ended
December 31, 2006
156,047 7.1
10,573 15.5
10,957 37.6
4,610 (1.6)
Nine months ended
December 31, 2005
206,801
12,331
12,228
4,512
Fiscal Year ended
March 31, 2006
Basic Earnings
per Share
Nine months ended
December 31, 2006
Nine months ended
December 31, 2005
Fiscal Year ended
March 31, 2006
(Note)

Diluted Earnings
per Share

Yen

Yen

134.31

-

72.55

-

69.57

-

Percentage for net sales, operating income, etc. represents the ratio of change from the same period of the previous fiscal year.

[Supplementary information on the consolidated results of operations]
The situation of Japanese economy for this nine-month period generally remained in the trend of gradual
recovery while we were afraid of a negative impact to revenues of the enterprises by the raise of the interest
rate due to the quantitative financial relief policy and lifting policy of the zero interest rate determined by the
Bank of Japan, which, however, affected limitedly to capital investments and individual consumptions. Under
such situation, we have made effort to reinforce our production capacity and selling capability to enhance ourbrand recognitions by upgrading the qualities of our basic products and continued to develop innovative
products with our techniques.
Also we decided to invest our operational resources intensively to Medical and Pharmaceutical businesses
and, consequently, we divested our subsidiary companies of store business, Nissho Corporation and Nissho
Drug Co., Ltd.
As a result, net sales for the nine months ended December 31, 2006 decreased by 6.6% from the same periodof the previous fiscal year to 145,796 million yen. Operating income decreased by 5.3% from the same periodof the previous fiscal year to 10,012 million yen and recurring income decreased by 16.6% from the same
period of the previous fiscal year to 9,139 million yen. Net income increased, due to the profit on sales of theshares of the subsidiary companies, by 85.0% to 8,530 million yen from the same period of the previous fiscal
year.
(2) Financial Position
Total Assets

Nine months ended
December 31, 2006
Nine months ended
December 31, 2005
Fiscal Year ended
March 31, 2006

Shareholder'sEquityRatio of Shareholder's Shareholder's Equity
Equity to Total Assets
per Share

Millions of Yen

Millions of Yen%

Yen

318,836

117,63836.5

1,831.78

327,635

108,82533.2

1,712.78

338,740

112,39033.2

1,767.69-1-[[ Cash Flows ]]Nine months ended
December 31, 2006
Nine months ended
December 31, 2005
Fiscal Year ended
March 31, 2006

Cash flows fromOperating activities

Cash flows from
Investing activities

Cash flows from
Financing activities

Cash and
Cash Equivalents

Millions of Yen

Millions of Yen

Millions of Yen

Millions of Yen

8,324

(730)

(17,931)39,757

3,092(21,064)

8,362

45,166

6,701(27,555)

15,712

49,914[Supplementary information on the changes in the financial position](1)Changes in the financial position
Total assets decreased by 19,904 million yen to 318,836 million yen from the end of previous fiscal year.
Current assets decreased by 1,580 million yen to 144,282 million yen and fixed assets decreased by 18,324
million yen to 174,553 million yen from the end of previous fiscal year. Fixed assets decreased mainly due to thedecrease in the tangible assets such as buildings and structures and land and the investment and others assets
such as investment securities and lease deposits.
Total liabilities decreased by 23,539 million yen to 201,197 million yen. Current liabilities decreased by 5,888
million yen to 105,396 mainly due to decrease of current portion of bonds and commercial paper, and fixedliabilities decreased by 17,651 million yen to 95,801 mainly due to long-term borrowings.
Shareholders’ equity including minority interests increased by 3,635 million yen to 117,638 million yen from theend of previous fiscal year, in which earned surplus increased by 4,141 million yen and valuation difference ofother investment securities from decreased by 2,699 million yen to 22,864 million yen, from the end of previous
fiscal year.
(2)Cash flows
Net cash provided by operating activities was 8,324 million yen, net cash used in investing activities was 730
million yen, net cash used in financing activities was 17,931 million yen. As a result, cash and cash equivalents at
the end of the period amounted to 39,757 million yen.
Net cash used in investing activities was mainly spent in acquisition of fixed assets and net cash used infinancing activities was mainly spent in repayments of bond and commercial paper.
[[ Reference ]]Consolidated Business Forecasts for the Fiscal Year ending March 31, 2007(From April 1, 2006 to March 31, 2007).
Sales
Recurring Income
Net Income
Millions of Yen

Millions of Yen

Millions of Yen

182,000
10,5008,200
Fiscal Year ended
March 31, 2007
(Reference) Projected Earnings per Share for the Fiscal Year ending March 31, 2007:

129.14 yen[Supplementary information on the business forecasts]

The business environment is anticipated to remain severe due to the concern of risks in increase of interest
rates and foreign currencies exchange fluctuations. We, however, continuously endeavor to develop new
products, as well as to reinforce the production capacity and selling capability in order to improve the businessperformance.
Thus, we forecast 182 billion yen of consolidated sales, 10.5 billion yen of consolidated recurring income and8.2 billion yen of consolidated net profit, for the fiscal year ending March 31, 2007.

Attention:

The above forecasts are based on the information available to the management as of the date of this report.
The actual results may differ from these forecasts due to various factors occurring hereafter.

-2-

Consolidated Balance Sheets(Unit: Millions of yen)
As of

As of

Increase

As ofDecember 31, 2006

March 31, 2006

(decrease)

December 31, 2005

PeriodAccount

Amount%Amount%AmountAmount%(ASSETS)
Current assets

144,282(1,580)139,738

Cash on hand and bank deposits

45,02153,395(8,374)47,911

Trade notes and accounts receivable

51,90045,794

6,105

46,848Inventories

39,66040,558(897)

39,471

Deferred tax assets

3,472

2,151

1,321

1,672

Others

4,757

4,320

436

4,160

Allowance for doubtful accounts

45.3

(529)

145,863

43.1

(357)

Fixed assets

174,55354.7

192,877

56.9

Tangible fixed assets

100,89931.6

106,195

33.6

57.3
32.5

106,654
44,195

26,955

3,565

27,916

23,079(5,082)

23,143

11,159

8,210

2,948

6,902

4,536

4,704

(167)

4,496

43,245

Machinery, equipment and vehicles

30,521

Land

17,997

Construction in progress
OthersConsolidation adjustments(325)
187,897(5,295)36,685Intangible fixed assets(171)(18,324)(6,560)

Buildings and structures

1,832

0.6

－

1,292

0.4

540

1,102

111

(111)

108

Goodwill

245

－

245

－

Others

1,586

1,180

406

993

Investments and other assets

71,820(13,568)

80,140Investment securities

65,80868,313(2,504)62,957345

2,405(2,060)2,340Long-term loans receivable
Deferred tax assets

22.5

85,389

25.2

395

431

(35)

531

4,856

11,003(6,146)

11,411Others

3,455

4,021

(565)

3,546

Allowance for doubtful accounts(3,040)(784)(2,255)(647)(19,904)

327,635

Lease deposits

Total assets

318,836100.0

338,740100.0(Note) Increase (decrease) represents the comparison between December 31, 2006 and March 31, 2006

-3-

42.7

0.3

24.5

100.0

Consolidated Balance Sheets

As of

PeriodAccount

December 31, 2006
Amount(decrease)

March 31, 2006%

(Unit: Millions of yen)
As of

Increase

As ofAmount%AmountDecember 31, 2005
Amount%(LIABILITIES)Current liabilities

105,39633.1

111,28532.8

31,424(5,888)

119,048(3,074)32,209Trade notes and accounts payables

28,350

Shorts-term borrowings

53,37044,174

9,195

46,691

Current portion of bonds

60

10,020(9,960)13,020

Other payables

3,874

4,626

(751)

4,436

Accrued income taxes

7,362

3,331

4,030

2,192

Accrued bonuses

2,433

1,606

826

1,101

Allowance for loss on clearance of business

1,954

－

1,954

－

Notes payables for plant and equipment

3,448

2,719

729

6,665

－

9,000

(9,000)

9,000

4,382

160

3,731

Commercial paper

36.3

Others4,543

Fixed liabilities

95,801(17,651)

98,131

Bonds

31,48031,030450

16,040Convertible-bond type bonds

14,00014,000－14,000Long-term borrowings

33,24047,038(13,798)

48,950

Deferred tax liabilities

12,991

15,054(2,063)

12,639Accrued pension and severance cost

2,761

2,978

(217)

3,079

Others

1,328

3,350

(2,022)

3,421

Total Liabilities

201,19763.1

224,737

66.3(23,539)

217,179

66.3

－

－

1,612

0.5

－

1,631

0.5

Capital－－28,663

8.5－

28,663

8.8

Capital surplus－－

29,972

8.9－

29,972

9.1

Earned surplus－－

34,545

10.2－

34,643

10.6

Valuation difference of other securities－－

25,563

7.5－

22,261

6.8

Foreign currency translation adjustment－－(5,705)(1.7)－(6,079)

(1.9)

30.0

113,452

33.5

30.0

with stock acquisition rights(MINORITY INTERESTS)
Minority interests(SHREHOLDERS’ EQUITY)

－

－

(648)

(0.2)

－

(634)

(0.2)

Total Shareholders’ equity－－

112,39033.2－

108,825

33.2

Total Liabilities, minority interests and shareholders' equity－－

338,740100.0－

327,635

100.0

96,606

30.3

―

―

―

―

―

Capital28,663

9.0

Capital surplus

29,973

9.4

―

―

―

―

―

Earned surplus

38,687

12.1

―

―

―

―

―

Treasury stock

(717)

(0.2)

―

―

―

―

―

Treasury stock(NET ASSETS)
Shareholders’ equity

19,704

6.2

―

―

―

―

―

Valuation differences of other securities

22,864

7.2

―

―

―

―

―

Foreign currency translation adjustments

Valuation and translation differences(3,160)

(1.0)

―

―

―

―

―

Minority interests

1,327

0.4

―

―

―

―

―

Total net assets

117,638

36.9

―

―

―

―

―

Total liabilities and net assets

318,836

100.0

―

―

―

―

―

(Note) Increase (decrease) represents the comparison between December 31, 2006 and March 31, 2006

-4-

Consolidated Statements of Income(Unit: Millions of yen)
PeriodAccount

Nine months ended

Nine months ended

Increase

Fiscal year ended

December 31, 2006

December 31, 2005

(decrease)

March 31, 2006

Amount%Amount%AmountAmount%Net sales

145,796100.0

156,047100.0(10,251)

206,801

100.0

Cost of sales

105,334

72.2

112,487

72.1(7,153)

149,971

72.5

Gross profit

40,461

27.8

43,55927.9(3,098)56,82927.5

Selling, general and administrative expenses

30,44920.932,98621.1(2,537)44,497

21.5

Operating income

10,012

6.9

10,5736.8(560)

12,3316.0

Non-operating income

1,526

1.0

2,447

1.5

(920)

2,705

1.3

Interest income

203

112

91

179

Dividend income

558

503

55

508

Exchange gain

395

1,407

(1,012)

1,475

Others

369

424

(55)

541

336

2,808

40

1,552

Non-operating expenses

2,399Interest expenses

1,200

1.6

2,062

1.3

1,160

Depreciation and amortization

281

－

281

－

Amortization of long-term prepaid expenses

197

69

128

94

Equity in losses of affiliates

534

495

39

702

Others

185

337

(152)

458

1.4

Recurring income

9,139

6.3

10,9577.0(1,818)

12,2285.9

Extraordinary gains

13,425

9.2

65

0.1

13,360201

0.1Profit on sale of fixed assets

22

14

8

112

Governmental subsidies received

666

19

647

19

12,70617

12,689

15

30

14

15

54

4,701

3,369

24

497
1,997

Gain on sale of investment securities
OthersExtraordinary losses
Loss on sale and disposal of fixed assets

5.1

7,353

2,651

1.7

271

247

Impairment loss on fixed assets

1,286

1,920

(633)

Allowance for loss on clearance of business

1,954

－

1,954

－

Loss on investment securities

268

－

268

－

Loss on disposal of inventories

112

109

3

195

Abnormal manufacturing cost

177

132

45

158

－

110

(110)

113

654

19

635

19

2,307

0

2,307

0

318

111

206

388

Severance payment
Advanced depreciation on fixed assets
Allowance for doubtful accounts
Others1.6

Net income before adjustment of taxes

15,212

10.4

8,371

5.4

6,840

9,060

4.4

Corporate, inhabitants and enterprise taxes

9,305

6.3

4,197

2.7

5,107

5,240

2.5

Adjustment for deferred taxes(2,625)

(1.8)

(321)

(0.2)

(2,303)

(540)

(0.2)

1

0.0

－

－

1

－

Minority share in net gain of consolidated subsidiaries
Minority share in net loss of consolidated subsidiaries
Net(Quarter) income

－

－

115

0.1

(115)

151

0.1

8,530

5.9

4,610

3.0

3,919

4,512

2.2

(Note) Increase (decrease) represents the comparison between the nine months ended December 31, 2006 and the nine months ended December 31,
2005.

-5-

Consolidated Statement of Shareholders’ Equity(Unit: Millions of yen)

Nine months ended December 31, 2006 (from April 1, 2006 to December 31, 2006 )Shareholders’ equity
CapitalBalance at March 31, 2006

Capitalsurplus28,663

Earnedsurplus29,972

Treasurystock

34,545

Total
shareholders'equity(648)
92,532(4,096)(4,096)

(91)

(91)

8,530

8,530

Increase (decrease) during the period
Dividend of surplus
Bonuses to directors and corporate auditors
Net (Quarter) income
Acquisition of treasury stock(76)

Disposal of treasury stock

1

Decrease in earned surplus due to addition of consolidated subsidiaries

(76)

8
(201)

9
(201)

Increaese (decrease) of the items other than shareholders’ equity during the period

Net increase (decrease) during the period
Balance at December 31, 2006

－
－

1

4,141

(68)

4,074

28,66329,97338,687(717)

96,606

Valuation and translation differences
Foreign
Valuation
currency
differences oftranslationotheradjustments
securities

Balance at March 31, 2006

25,563(5,705)

Total
valuation andtranslationdifferences

19,858

Minority
interests

1,612

Total net
assets114,003

Increase (decrease) during the period
Dividend of surplus－(4,096)

Bonuses to directors and corporate auditors

－

(91)

Net (Quarter) income

－

8,530

Acquisition of treasury stock

－

(76)

Disposal of treasury stock－9

Decrease in earned surplus due to addition of consolidated subsidiaries

－

(201)

Increase (decrease) of the items other than shareholders’ equity during the period(2,699)

2,544

(154)

(284)

(439)

Net increase (decrease) during the period(2,699)

2,544

(154)

(284)

3,635

Balance at December 31, 2006

22,864(3,160)19,704

1,327

117,638-6-

Consolidated Statements of Cash Flows
PeriodAccount

Nine months ended
December 31, 2006
AmountNine months ended
December 31, 2005
Amount(Unit: Millions of yen)
Fiscal year ended
March 31, 2006
AmountCash flows from operating activities
Net income before adjustment for taxes
Depreciation and amortization
Impairment loss on fixed assets
Amortization of consolidation adjustments
Amortization of goodwill
Equity in loss of an affiliate
Allowance for doubtful accounts
Allowance for loss on clearance of business
Increase (decrease) in allowance for doubtful accounts
Interest and dividend income
Interest expenses
Exchange loss (gain)
Profit on sales of shares of subsidiary company
Decrease (increase) in trade receivables
Decrease (increase) in inventories
Increase (decrease) in trade payables
Decrease (increase) in other assets
Increase (decrease) in other liabilities
Bonuses to directors and corporate auditors
Other non-operating income/expenseand extraordinary income/losses
SubtotalInterest and dividends received
Interest paid
Other revenues
Other expenditures
Income taxes paid
Cash flows from operating activities

15,212
9,041
1,286
－
115
534
2,307
1,954
35
(762)
1,200
(34)
(12,706)(4,574)(3,186)
601
(700)
1,739
(96)
773

8,371
8,982
1,920
20
－
495
－
－
(1)
(616)
1,160
(994)
－
(6,086)(4,932)
2,230
(860)
(867)
(107)
283

9,060
12,315
1,997
27
－
702
－
－
131
(688)
1,552
(1,377)－(4,893)(5,754)
1,118(1,371)
(599)
(107)
514

12,740843(1,266)
1,472(212)(5,253)
8,324

8,999
516
(1,226)704(361)(5,540)
3,092

12,628702(1,467)
1,103(597)(5,667)
6,701(4,263)
2,677(2,244)24(517)
19,372(14,944)
20
(833)
－
48
(112)
40
(730)

(3,461)
3,266(9,501)
3,125
(26)
－
(14,331)
178
－
(343)
96
(66)
0
(21,064)(5,067)
4,244(9,504)
3,125
(26)
－
(20,359)375－(1,421)
1,144
(67)
0
(27,555)

5,749(9,000)
9,984(10,299)－(10,030)
9
(76)
－
(205)
(4,062)0(17,931)102(10,234)
49,91477
39,7575,781
2,000
10,510(7,836)
－
(10)
0
(48)
69
(274)
(1,821)
(7)
8,362
901
(8,709)53,734141
45,1662,888
2,000
13,384(12,260)
14,922(3,020)
1
(63)
69
(356)
(1,840)(11)
15,712
1,180(3,961)53,734141
49,914

Cash flows from investing activities
Deposits in time deposits
Proceeds from time deposits
Payments for acquisition of securities
Proceeds from sales of securities
Payments for acquisition of newly consolidated subsidiary
Proceeds from sale on share of subsidiay company divested
Payments for acquisition of fixed assets
Proceeds from sales of fixed assets
Increase (decrease) in short-term loans receivable
Lending of loans
Collections of loans receivable
Payments for other investments
Proceeds from other investments
Cash flows from investing activities
Cash flows from financing activities
Net increase (decrease) in short-term borrowings
Net increase (decrease) in commercial paper
Proceeds from long-term borrowings
Repayment of long-term borrowings
Proceeds from issuance of bonds
Payments for redemption of bonds
Proceeds from disposal of treasury stock
Payments for acquisition of treasury stock
Proceeds from sale and lease backRepayments of finance lease obligation
Payments for dividends
Other payments
Cash flows from financing activities
Effect of exchange rate changes on cash and cash equivalents
Increase (decrease) in cash and cash equivalents
Balance of cash and cash equivalents at the beginning of the period
Balance of cash and cash equivalents in new consolidated subsidiary at the beginning of the period

Balance of cash and cash equivalents at the end of the period-7-

(Segment information)
1. Segment information by business category(1) Nine months ended December 31, 2006 (from April 1, 2006 to December 31, 2006 )MedicalPharma-Glass &

Equipment

ceuticalMaterials(Unit: Millions of yen)

Store

Other

Total

Eliminations/Corporate

Consolidated

Net sales and operating income
Net sales(1)Sales to third parties

71,82731,995

10,18630,973813

145,796

－

3

－

2,538

－

204

2,746

(2,746)－

71,831

31,995

12,72430,973

1,018

148,542(2,746)

145,796

Operating expenses

61,30529,574

11,32630,702865

133,774

2,009

135,784

Operating income

10,525

2,421

1,398

270

152

14,767(4,755)

10,012(2)Inter-segment sales and transfers
Total(2) Nine months ended December 31, 2005 (from April 1, 2005 to December 31, 2005)
MedicalPharma-Glass &

Equipment

ceuticalMaterials

145,796(Unit: Millions of yen)
Store

Other

Total

Eliminations/Corporate

Consolidated

Net sales and operating income
Net sales(1)Sales to third parties

67,944

26,205

8,696

52,218982

156,047

－

－

－

2,557

25

385

2,967

(2,967)－

67,944

26,205

11,25352,243

1,367

159,015(2,967)156,047

Operating expenses

57,222

24,3849,978

51,699915

144,200

1,274

145,474

Operating income

10,721

1,821

1,275

544

451

14,814(4,241)

10,573(2)Inter-segment sales and transfers
Total(3) Fiscal Year ended March 31, 2006 (From April 1, 2005 to March 31, 2006)
MedicalPharma-Glass &

Equipment

ceuticalMaterials

156,047(Unit: Millions of yen)
Store

Other

Total

Eliminations/Corporate

Consolidated

Net sales and operating income
Net sales(1)Sales to third parties

90,86835,21911,93367,261

1,518

206,801

－

0

－

3,401

35

516

3,953

(3,953)－90,86835,21915,33567,296

2,035

210,755(3,953)

206,801

Operating expenses

77,43833,10813,49966,718

1,506

192,271

2,197

194,469

Operating income

13,429

2,111

1,835

577

528

18,483(6,151)

12,331(2)Inter-segment sales and transfers
Total

Notes 1.

206,801

Classification of business categories and main products in each business category
Business categories are classified based on the proximity in terms of purposes and manners of usage of the products in the market.
Main products belonging to each business categories are as follows:

Main products

Business category

Medical Equipment

Dialyzers, blood tubing sets, injection needles, syringes, and infusion sets, etc.

Pharmaceutical

Half-type and full-type kits, double-bag kits, pre-filled syringes, dialysate solution, and circulatory drugs, etc.

Glass & Materials

Glass for pharmaceutical containers, glass for thermos bottles, glass for lighting purposes, stoppers for plastic containers
and rubber stoppers, etc.

Store

Fresh meat and fish, vegetables, fruits, processed food, daily foods, frozen foods, general groceries and medicine, etc.

Other

Machinery for manufacture of medical equipment and real estate rental income, etc.

Notes 2.

Operating expenses of “Eliminations/Corporate” for the nine months ended December 31, 2006, the nine months ended December 31, 2005 and thefiscal year ended March 31, 2006 included unallocated corporate costs of 4,755 million yen, 4,241 million yen and 6,151 million yen, respectively. The
unallocated corporate costs consisted primarily of the parent companies’ research and development costs and headquarters administration costs.

-8-

2. Segment information by geographical area
(1) Nine months ended December 31, 2006 (from April 1, 2006 to December 31, 2006 )Japan

America

Europe(Unit: Millions of yen)

Asia

Total

Eliminations Consolidated/Corporate

Net sales and operating income
Net sales(1)Sales to third parties

125,604

12,375

5,139

2,676

145,796－(2)Inter-segment sales and transfers

18,017

519

3

9,022

27,563(27,563)－

143,621

12,894

5,143

11,699173,359(27,563)

145,796

Operating expenses

128,571

13,482

4,915

11,199158,168(22,384)

135,784

Operating income (loss)

15,050

(587)

227

500

15,191(5,179)10,012Total(2) Nine months ended December 31, 2005 (from April 1, 2005 to December 31, 2005)
Japan

America

Europe145,796(Unit: Millions of yen)
Asia

Total

Eliminations/Corporate

Consolidated

Net sales and operating income
Net sales(1)Sales to third parties

139,593

10,915

4,510

1,028

156,047－(2)Inter-segment sales and transfers

12,075

326

4

8,017

20,423(20,423)－

151,668

11,241

4,515

9,045

176,471(20,423)

156,047

Operating expenses

136,571

11,502

4,655

8,482

161,212(15,737)

145,474

Operating income (loss)

15,097

(260)

(140)

563

15,259(4,686)

10,573Total(3) Fiscal Year ended March 31, 2006 (From April 1, 2005 to March 31, 2006)
Japan

America

156,047(Unit: Millions of yen)

Europe

Asia

Total

Eliminations/Corporate

Consolidated

Net sales and operating income
Net sales(1)Sales to third parties

184,154

14,682

6,312

1,652

206,801－(2)Inter-segment sales and transfers

15,829450

410,80327,088(27,088)－

199,983

15,132

6,317

12,455

233,890(27,088)

206,801

Operating expenses

181,129

15,7106,558

11,597214,996(20,526)

194,469

Operating income (loss)

18,854

(577)

(241)

858

18,893(6,562)

12,331

Total

206,801

Note 1. Operating expenses of “Eliminations and Corporate” for the nine months ended December 31, 2006, the nine months ended December 31,
2005 and the fiscal year ended March 31, 2006 included unallocated corporate costs of 4,755 million yen, 4,241 million yen and 6,151 million
yen, respectively. The unallocated corporate costs consisted primarily of the parent company’s research and development costs and theheadquarters administration costs.

Note 2. Classification of countries or areas is based on geographical proximity.
Note 3. The major countries and areas included in each geographical area are as follows
America …….. The United States of America and Brazil
Europe ……… Belgium
Asia …………. China, Thailand and Singapole-9-3. Overseas sales(1) Nine months ended December 31, 2006 (from April 1, 2006 to December 31, 2006 )(Unit: Millions of yen)

America
1. Overseas sales

Europe23,237

10,867Asia
5,404

2. Consolidated net sales

39,508145,796

3. Percentage of overseas sales to consolidated net sales (%)

15.9%

7.5%

(2) Nine months ended December 31, 2005 (from April 1, 2005 to December 31, 2005)

1. Overseas sales

3.7%

27.1%

(Unit: Millions of yen)

America

EuropeAsia

21,477

10,285

4,348

13.7%

6.6%

2.8%

2. Consolidated net sales

Total
36,111
156,047

3. Percentage of overseas sales to consolidated net sales (%)(3) Fiscal Year ended March 31, 2006 (From April 1, 2005 to March 31, 2006)

23.1%(Unit: Millions of yen)
America

1. Overseas sales

Europe28,876

14,073Asia
6,407

2. Consolidated net sales

Total
49,358206,801

3. Percentage of overseas sales to consolidated net sales (%)

14.0%

6.8%

3.1%

Note 1. Overseas sales represent those of the Company and the consolidated subsidiaries to countries and areas outside of Japan.
Note 2. Classification of countries or areas is based on geographical proximity.
Note 3. The major countries and areas included in each geographical area are as follows
America …
…..
Europe ……
…
Asia ………
….

The United States of America, Canada and Brazil
Belgium, Denmark and Germany
China, India, Indonesia, Taiwan and Thailand

Production, Orders received and Sales
1.Production

Business segment

Total

Nine months ended
December 31, 2006
Ratio to theAmountProduced(Millions of yen)
Fiscal year ended
March 31, 2006

Nine months ended
December 31, 2005
Ratio to theAmountsame period of
the previous
fiscal year (%)

Produced

Ratio to theAmountsame period of
the previous
fiscal year (%)

Producedsame period of
the previous
fiscal year (%)

Medical Equipment

54,215

8.7

49,85311.7

65,453

11.1

Pharmaceutical

30,87015.7

26,67839.4

35,867

40.8

Glass & Materials

2,653

6.5

2,491

2.7

3,415

(6.9)

Other

502

2.6

489

5.2

912

84.9

Total

88,242

11.0

79,513

19.3

105,649

19.3

Note 1. Amounts produced are calculated based on average selling prices.
Note 2. The above amounts are after eliminations of the intersegment transactions.
Note 3. The above amounts do not include the related consumption taxes.

2. Orders received
Since we adopt the production system based on estimated orders, there is nothing applicable hereto regarding the amount and thebalance of orders received.

3. Sales- 10 -

23.9%

Business segment

Nine months ended
December 31, 2006
Ratio to theSales
AmountMedical Equipment
Pharmaceutical
Glass & Materials
Store
Other
Total

same period of
the previous
fiscal year (%)

Nine months ended
December 31, 2005
Ratio to theSales
Amountsame period of
the previous
fiscal year (%)(Millions of yen)
Fiscal year ended
March 31, 2006
Sales
AmountRatio to thesame period of
the previous
fiscal year (%)

71,827

5.7

67,944

8.6

90,86810.1

31,99522.1

26,20534.3

35,21934.4

10,186

17.1

8,696

0.3

11,933

2.3

30,973(40.7)

52,218(3.6)

67,261(5.1)

813(17.2)

982

16.0

1,518

37.9

145,796(6.6)

156,047

7.1

206,801

7.5

Note 1. The above amounts are after eliminations of the intersegment transactions.
Note 2. The above amounts do not include the related consumption taxes.

- 11 -